Inside the Electrome Platform, Bioelectric Therapy at Hyperscaler Scale
How Pulsed Short Wave Therapy (PSWT), an FDA cleared bioelectric modality, is becoming a software-defined platform for chronic pain and recovery.
Pulsed Short Wave Therapy (PSWT) is a clinically precise form of pulsed electromagnetic field therapy that the FDA has cleared for the treatment of musculoskeletal pain and edema. The Electrome platform turns that modality into a software defined system, pairing FDA cleared hardware with adaptive AI coaching, longitudinal outcomes data, and a partner network spanning providers, retailers, and affiliates.
From device to platform
Devices report telemetry, patients log outcomes, and the platform learns. That feedback loop is what allows PAINKILLER to deliver personalized care at the scale of consumer software, while remaining grounded in peer reviewed bioelectric science.
Citations
How Pulsed Short Wave Therapy (PSWT), an FDA cleared bioelectric modality, is becoming a software-defined platform for chronic pain and recovery.
More storiesKeep reading
James, A Veteran Reclaims His Mornings
After two decades of service related back pain, James found a routine that finally let him start his day pain free.
How PSWT Works, A Plain English Look at the Bioelectric Mechanism
What pulsed electromagnetic fields actually do at the cellular level, and why that matters for pain.
Electrome Corporation Advances Toward Pre-Seed Financing Following Launch of ActiPatch® Platform and Progress in LymeCure Research Program
Electrome prepares for a StartEngine pre-seed financing while reporting commercial momentum on the ActiPatch® experience and early in vitro progress in the LymeCure research initiative.